Lupus and the nervous system

Lupus

Volumn 12, Issue 12, 2003, Pages 871-

  D'Cruz, David ^a   Hughes, Graham R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; STEROID;

ANTIPHOSPHOLIPID SYNDROME; CLUSTER HEADACHE; DIFFERENTIAL DIAGNOSIS; EDITORIAL; LUPUS ERYTHEMATOSUS; MEDICAL DECISION MAKING; NERVOUS SYSTEM; NEUROPSYCHIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SERODIAGNOSIS;

COMORBIDITY; FEMALE; HUMANS; INCIDENCE; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MALE; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0345862385     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu494ed     Document Type: Editorial

References (6)

1. Hughes GRV. Migraine, memory loss and 'multiple sclerosis'. Neurological features of the antiphospholipid (Hughes) syndrome. Postgrad Med J 2003; 79: 81-83.
2. Hughes GRV. Thrombosis, abortion, cerebral disease and the lupus anticoagulant. BR Med J 1983; 287: 1088-1089.
3. D'Cruz DP, Mellor-Pita S, Joren B et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol 2003 (in press).
4. ACR Ad Hoc Committee on Neuropsychiatric Lupus. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
5. Sanna G, Bertolaccini ML, Cuadrado MJ, Laing H, Mathieu, Hughes GRV. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30: 985-992.
6. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215-1222.